The Hydroxychloroquine Debate–As The U.S. Orders 29 Million Doses, Initial Champion France Remains Divided Over Its Efficacy [Forbes]
New York Times Company (The) (NYT)
Last new york times company (the) earnings: 2/6 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.nytco.com/investors/default.aspx
Company Research
Source: Forbes
The debate over usinghydroxychloroquine to treat COVID-19 patients rages on, particularly as news emerged that President Trump has stockpiled 29 million doses. The main proponent of using the drug is a doctor, based in Marseille, France, who published a study claiming multiple benefits–which has deeply divided the medical profession and left many skeptical. Here’s an outline of the current issues.A pharmacy worker with hydroxychloroquine (marketed under the name Plaquenil) on March 25, 2020 in... [+]Paris, France.Getty ImagesHydroxychloroquine is an anti-malarial drugPlaquenil, and is slightly less potent than chloroquine (also used for treating malaria), which is related to quinine (which itself is an ingredient of tonic water, although not in any large amount). Both are often given to people travelling in areas where the risk of contracting malaria is high.A French doctor,The report, published online40 coronavirus patients were given hydroxychloroquine, with more than half experienc
Show less
Read more
Impact Snapshot
Event Time:
NYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NYT alerts
High impacting New York Times Company (The) news events
Weekly update
A roundup of the hottest topics
NYT
News
- Another line of attack: White House sets up a hall of shame for news outlets [Los Angeles Times (CA)]Los Angeles Times
- Another line of attack: White House sets up a hall of shame for news outlets [Yahoo! Finance Canada]Yahoo! Finance Canada
- Erika Kirk speaks at New York Times DealBook Summit [FOX News]FOX News
- Why The New York Times Company Stock Gained 13% in November [Yahoo! Finance]Yahoo! Finance
- Bald eagle thought to be shot in Massachusetts was actually injured in eagle fight, vets believe [CBS News]CBS News
NYT
Earnings
- 11/5/25 - Beat
NYT
Sec Filings
- 11/10/25 - Form 4
- 11/6/25 - Form 144
- 11/5/25 - Form 10-Q
- NYT's page on the SEC website